Johnson & Johnson ($JNJ) has won a lawsuit against a long-time distribution partner in China. While the amount of money involved may seem puny, it appears to be a big victory in a country that is terribly protective of its domestic drug distributors.
In a bit of drug family planning, Warner Chilcott ($WCRX) has sued Watson Pharmaceuticals ($WPI) to prevent it from putting out a generic version of its oral contraceptive Lo Loestrin Fe.
A Merck unit has pleaded guilty to a criminal misdemeanor charge as part of the whopping $950 million settlement of a federal probe into the illegal marketing of Vioxx.
An Arizona man lost a federal court appeal of his lawsuit claiming that a Medtronic ($MDT) pain pump left him paraplegic.
Alex Gorsky's name has surfaced in the U.S. government's Risperdal marketing lawsuit just weeks before he is supposed to step up into the role of CEO at Johnson & Johnson.
Synthes is fighting an ex-employee in court alleging, among other things, illegal use of proprietary information. This week, he's fighting back.
Bayer failed to stop 8 women from seeking class-action status for their sex-discrimination claims against the company.
A U.S. judge sided with death row inmates who sued the FDA for importing a drug used in lethal injections. The prisoners had claimed the agency's decision to allow foreign versions of sodium thiopental into the U.S. violated its own drug-approval rules.
Two plaintiffs' lawyers experienced in pharma liability litigation have been tapped to lead the group managing thousands of suits alleging that Takeda Pharmaceutical's diabetes drug Actos caused bladder cancer, Bloomberg reports.
AstraZeneca is seeking an injunction to block Seroquel copies at least until a court can review its claims. The drugmaker says the FDA shouldn't be allowed to usher generic Seroquel onto the market until Dec. 2, when data exclusivity expires.